Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Dynavax Technologies Corporation (DVAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Dynavax's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.800 +0.460    +4.06%
19/04 - Closed. Currency in USD ( Disclaimer )
After Hours
11.800
-0.000
-0.000%
0:54:09 - Real-time Data
  • Volume: 6,833,903
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 11.250 - 11.850
Type:  Equity
Market:  United States
Dynavax 11.800 +0.460 +4.06%

Dynavax Technologies Corporation Latest Cash Flow Statement

 
Use the Dynavax cash flow statement to assess the changes in DVAX's cash and cash equivalents.

The DVAX cash flow chart shows Net Income, Cash from Operating, Financing and Investing Activities, as well as Dynavax free cash flow, yield and ending cash balance.
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 0.219 14.29 3.43 -24.33
Cash From Operating Activities 13.77 31.13 28.05 27.62
Depreciation/Depletion 1.96 1.87 1.79 1.66
Amortization - - - -
Deferred Taxes - - - -
Non-Cash Items 4.94 7.33 5.67 20.54
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 0.601 0.703 0.678 0.032
Cash Interest Paid 2.82 - 2.82 -
Changes in Working Capital 6.65 7.64 17.16 29.76
Cash From Investing Activities -20.24 -106.07 24.72 -52.33
Capital Expenditures -1.72 -0.347 -0.751 -1.28
Other Investing Cash Flow Items, Total -18.52 -105.73 25.47 -51.05
Cash From Financing Activities 1.78 2.99 -0.294 -3.09
Financing Cash Flow Items - - - -
Total Cash Dividends Paid - - - -
Issuance (Retirement) of Stock, Net 1.78 2.99 -0.294 -3.09
Issuance (Retirement) of Debt, Net - - - -
Foreign Exchange Effects -0.1 - - -
Net Change in Cash -4.22 -72.26 52.47 -27.65
Beginning Cash Balance 154.5 226.77 174.35 202
Ending Cash Balance 150.28 154.51 226.82 174.35
Free Cash Flow 1.29 24.82 24.94 47.09
Free Cash Flow Growth -94.82 -0.51 -47.03 40.45
Free Cash Flow Yield 0.666 1.62 1.64 2.1
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DVAX Price Commentary

Write your thoughts about Dynavax Technologies Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roy Martinez
Roy Martinez Sep 23, 2021 2:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold at $18,60 with nice $10 gain Will buy back if there is the anticipated market correction later this year.Believe stock could easily reach $25 plus when looking at its Financials and Drug research/production.
Joohan Tan
Joohan Tan Aug 11, 2021 14:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30 once covid 19 vaccine success
Roy Martinez
Roy Martinez Aug 11, 2021 14:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope so; still looking good after buying at $7,25
Marvin Lawrence
Marvin Lawrence Feb 01, 2021 19:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big year for DVAX, numerous contracts signed, expecting to hit past the 20s soon
Marvin Lawrence
Marvin Lawrence Feb 01, 2021 19:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big year for DVAX, numerous contracts signed
Roy Martinez
Roy Martinez Jul 25, 2020 8:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Got out at $9.7 with 100% profit. May buy again if price sinks further but a volatile ride.
Avatar Bond
Avatar Bond Jul 25, 2020 8:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now this will be on the rise...earnings coming next week and will rocket!
Avatar Bond
Avatar Bond Jul 16, 2020 14:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whoever thinks this will rocket hit like button!
Saeed Ahmed
Saeed Ahmed Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There Hep B Vaccine will produce revenue if they don't find a vaccine for covid 19
Rishabh Dhivare
Rishabh Dhivare Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As of today India anounced the vaccine for COVID-19,
Saeed Ahmed
Saeed Ahmed Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes but India's process of getting a vaccine into the market is different there is less red tape and less regulations to follow.
Roy Martinez
Roy Martinez Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes but their revenue recent results were very poor !
Avatar Bond
Avatar Bond Jun 24, 2020 13:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bright future!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email